SCHEMBL995782

SCHEMBL995782

CCCCC(Oc1ccccc1C(F)(F)F)N1CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.40
PTGS2 P35354 1/20 0.40
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
PPARG P37231 1/20 0.38
DRD2 P14416 4/20 0.37
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
SLC6A4 P31645 1/20 0.36
ALDH1A1 P00352 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
MC4R P32245 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SSTR1 P30872 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL995182 0.80 L3MBTL1 (0.43) ADRA2AADRA2BADRA2CDRD2SLC6A4
SCHEMBL12130571 0.78 TDP1 (0.45) SLC6A4HRH3SLC6A2
SCHEMBL12130553 0.76 SLC6A2 (0.42) LTA4HOPRM1OPRL1SLC6A4HRH3
SCHEMBL994992 0.76 SLC6A4 (0.48) LTA4HADRA2AADRA2BDRD2OPRM1
SCHEMBL991525 0.75 HTR7 (0.47) DRD2ALDH1A1HRH3CYP1A2CYP2D6
SCHEMBL12130554 0.75 HRH3 (0.43) LTA4HOPRM1OPRL1SLC6A4HRH3
SCHEMBL12130449 0.75 HRH3 (0.43) LTA4HOPRM1OPRL1SLC6A4HRH3
SCHEMBL991769 0.74 HTR7 (0.39) DRD2SLC6A4ALDH1A1HRH3SLC6A2
SCHEMBL994382 0.74 SLC6A2 (0.45) LTA4HSLC6A4ALDH1A1HRH3SLC6A2
SCHEMBL12130575 0.73 PTGES (0.44) ADRA2AADRA2BADRA2CPPARGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011008666-A2 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS THERAVANCE, INC. (US) 2011-01-20 WO disclosed